Showing results (1-10 of 364) with videos related to
Sort By:
Pageof 37
Frontiers in Medicine|March 14, 2017
Factors XI and XII as Targets for New AnticoagulantsJeffrey I Weitz, James C FredenburghArteriosclerosis, Thrombosis, and Vascular Biology|December 23, 2017
2017 Scientific Sessions Sol Sherry Distinguished Lecture in Thrombosis: Factor XI as a Target for New AnticoagulantsJeffrey I Weitz, James C FredenburghJournal of Thrombosis and Haemostasis : JTH|January 22, 2025
Exosite crosstalk in thrombinJames C Fredenburgh, Jeffrey I WeitzJournal of Thrombosis and Haemostasis : JTH|April 28, 2023
News at XI: moving beyond factor Xa inhibitorsJames C Fredenburgh, Jeffrey I WeitzJournal of Thrombosis and Haemostasis : JTH|October 13, 2020
New anticoagulants: Moving beyond the direct oral anticoagulantsJames C Fredenburgh, Jeffrey I WeitzHamostaseologie|April 16, 2021
Factor XI as a Target for New AnticoagulantsJames C Fredenburgh, Jeffrey I WeitzJournal of Thrombosis and Haemostasis : JTH|February 18, 2026
Formation of a ternary polyphosphate-thrombin-fibrin complex attenuates thrombin activityXintong Yao, James C Fredenburgh, Jeffrey I WeitzJournal of Thrombosis and Haemostasis : JTH|July 13, 2025
Effects of milvexian alone or with heparin on catheter-induced clotting and thrombin generationRuiqi Yin, James C Fredenburgh, Jeffrey I WeitzJournal of the American College of Cardiology|November 4, 2017
A Test in Context: D-DimerJeffrey I Weitz, James C Fredenburgh, John W EikelboomCirculation Research|October 2, 2012
Oral direct factor Xa inhibitorsCalvin H Yeh, James C Fredenburgh, Jeffrey I WeitzPageof 37